Bionaut Pharmaceuticals
Cambridge
About Bionaut Pharmaceuticals
Bionaut Pharmaceuticals is a biotechnology company that discovers and advances small molecule drug candidates. The company’s Sentinel Pathway Reporter System has product driven applications, such as initiation and development of drug discovery programs, identifying biomarkers for clinical trials, validating existing drug candidates for a specific disease pathway, and identifying new indications for existing drug candidates and known drugs; and research-driven applications, including deciphering pathways and their relationships, and identifying genes. Bionaut Pharmaceuticals was founded in 2000 and is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2003)
- Website: bionautpharma.com
- Phone: +1 617-401-2215
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/bionaut-pharmaceuticals-1856755 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.